Histone Deacetylase 3 Depletion in Osteo/Chondroprogenitor Cells Decreases Bone Density and Increases Marrow Fat by Razidlo, David F. et al.
Histone Deacetylase 3 Depletion in Osteo/
Chondroprogenitor Cells Decreases Bone Density and
Increases Marrow Fat
David F. Razidlo
1., Tiffany J. Whitney
1., Michelle E. Casper
1, Meghan E. McGee-Lawrence
1, Bridget A.
Stensgard
1, Xiaodong Li
1, Frank J. Secreto
1, Sarah K. Knutson
2, Scott W. Hiebert
2, Jennifer J.
Westendorf
1*
1Department of Orthopedic Surgery and Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, United States of America, 2Department
of Biochemistry, Vanderbilt University, Nashville, Tennessee, United States of America
Abstract
Histone deacetylase (Hdac)3 is a nuclear enzyme that contributes to epigenetic programming and is required for embryonic
development. To determine the role of Hdac3 in bone formation, we crossed mice harboring loxP sites around exon 7 of
Hdac3 with mice expressing Cre recombinase under the control of the osterix promoter. The resulting Hdac3 conditional
knockout (CKO) mice were runted and had severe deficits in intramembranous and endochondral bone formation. Calvarial
bones were significantly thinner and trabecular bone volume in the distal femur was decreased 75% in the Hdac3 CKO mice
due to a substantial reduction in trabecular number. Hdac3-CKO mice had fewer osteoblasts and more bone marrow
adipocytes as a proportion of tissue area than their wildtype or heterozygous littermates. Bone formation rates were
depressed in both the cortical and trabecular regions of Hdac3 CKO femurs. Microarray analyses revealed that numerous
developmental signaling pathways were affected by Hdac3-deficiency. Thus, Hdac3 depletion in osterix-expressing
progenitor cells interferes with bone formation and promotes bone marrow adipocyte differentiation. These results
demonstrate that Hdac3 inhibition is detrimental to skeletal health.
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Introduction
The skeleton is a dynamic organ composed of more than 200
bones that develop via two distinct processes. Intramembranous
ossification occurs when mesenchymal cells condense and
differentiate into osteoblasts to form the flat bones of the skull
and clavicles. In contrast, the long bones develop via a process of
endochondral ossification that involves the recruitment of
osteoblasts to a cartilaginous template. Mature osteoblasts secrete
collagens and other proteins to form an organic matrix (osteoid)
that is mineralized when inorganic salts are brought to the site via
the circulation. Osteoblasts are derived from several multipotent
progenitors, including mesenchymal cells, neural crest cells and
pericytes. Osteoblast development requires the expression of
several transcription factors (e.g. Runx2 [1,2] and osterix [3])
and the coordinated activation of numerous developmental
signaling pathways [4]. Cells committed to the osteoblast lineage
mature through successive stages of proliferation (pre-osteoblasts),
cell cycle exit and production of matrix proteins (osteoblasts), and
finally, terminal differentiation into mechanosensory osteocytes or
bone lining cells. If progenitor cells do not receive the proper
signals for osteogenesis, as in the case of Runx2-deficiency, they
have an increased propensity to differentiate into adipocytes [5,6].
Histone deacetylases (Hdacs) are enzymatic components of large
multi-protein complexes that remove acetyl groups from lysine
side chains of histones and other proteins. They contribute to
epigenetic programming and regulation of gene expression during
development and throughout life. The human and mouse
genomes encode 18 Hdacs that are classified into four groups on
the basis of their structure and function [7]. Hdac3 (OMIM
605166) is part of class I, which also includes Hdac1, 2, and 8.
Although class I Hdacs are broadly expressed, these predom-
inantly nuclear enzymes have distinct developmental roles
[8,9,10,11,12,13]. By comparison, class II Hdacs (Hdacs 4, 5, 6,
7, 9, 10) travel between the nuclear and cytoplasmic compart-
ments and have more tissue restricted expression patterns
[7,14,15,16,17]. Hdac3 binds several class II Hdacs [18,19] and
co-repressor proteins, notably nuclear receptor co-repressor
(NCoR) and silencing mediator of retinoid and thyroid hormone
receptors (SMRT), to form large multi-protein complexes
[20,21,22]. These multi-protein complexes are recruited to specific
DNA sequences and chromatin substrates by transcription factors.
Several Hdacs contribute to skeletal development [7,23]. Hdac4
is expressed in prehypertrophic chondrocytes [14]. Germline
deletion of Hdac4 caused premature ossification of the developing
bones, while Hdac4 overexpression prevented chondrocyte
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modestly enhanced trabecular bone formation [15]. Recently,
Hdac8 was shown to be essential for neural crest progenitor cell
differentiation and skull bone formation [13]. Hdac4 and Hdac6
bind and inhibit the activity of Runx2, a transcription factor
essential for osteoblast development [14,24,25]. Hdac3 also
interacts with Runx2 to repress the expression of osteoblast-
specific genes, osteocalcin and bone siaoloprotein, in vitro
[24,26,27,28,29]. Suppression of Hdac3 in immortalized osteo-
blast cell lines by RNA interference promoted the expression of
these genes and other markers of osteoblast maturation [24].
Germline Hdac3-deficiency caused embryonic lethality at approx-
imately 9 days post coitum [11,12], several days before skeletons
form in the mouse embryo. In this study, we determined the
consequences of Hdac3 depletion on bone formation by crossing
mice with loxP sites flanking exon 7 of Hdac3 [11] to mice wherein
Cre recombinase is expressed from the endogenous osterix (Osx)
promoter [30]. The data presented here show that Hdac3 depletion
impaired both trabecular and cortical bone properties and
promoted bone marrow adipogenesis.
Results
Hdac3 Conditional Knockout Mice Have Defects in
Intramembranous Bone Formation
The effects of Hdac3 depletion on skeletal maturation were
determined by crossing Hdac3
fl/2 mice [11,31] with mice
expressing Cre recombinase from the osterix (Osx) promoter
[30]. This breeding strategy eventually created five groups of
progeny: wildtype (Hdac3
fl/+:Cre
2), heterozygotes (Hdac3
+/2:
Cre
+ or 2 or Hdac3
fl/2:Cre
2; Hets), conditional heterozygotes
(Hdac3
fl/+:Cre
+; CHet), conditional knockouts with a single
germline null allele (Hdac3
fl/2:Cre
+;C K O ) ,a n do s t e r i x - d r i v e n
CKO (Hdac3
fl/fl:C r e
+;C K O Osx) (Figure 1A). Immunoblot,
qPCR, and microarray analyses of parietal bone protein and
mRNA extracts from 4 to 5 day- old mice demonstrated that
Hdac3 levels were significantly reduced in both groups of
CKO mice (Figure 1B and Table 1). The expression of other
Hdacs was not altered (data not shown). Hdac3 CKO and
CKOOsx mice were indistinguishable in size at birth from
wildtype and heterozygous littermates, but were smaller at the
time of weaning and remained smaller throughout their
lifespan, with male and female CKO animals being approx-
imately 40% and 20% smaller than wildtype littermates,
respectively (Figure 1C). Heterozygous mice were not signif-
icantly different in size and weight from wildtype animals
(Figure S1). The Hdac3 CKO and CKOOsx mice had shorter
lifespans with some mice dying as early as 3 weeks of age from
undetermined causes (Figure 1D). The oldest CKO mouse
survived 77 weeks, but was still outlived by heterozygous and
wildtype mice.
The consequences of Hdac3 depletion in osterix-expressing cells
on skeletal development were examined by whole mount skeletal
staining. One day-old Hdac3 CKO mice exhibited grossly normal
skeletal patterning with both cartilaginous and calcified skeletal
elements as detected by Alician blue and Alizarin red dyes,
respectively (Figure 2A). However, early calvarial development
was impaired (Figure 2B–2D). Parietal bone formation was
notably delayed in Hdac3 CKO mice. Microcomputed tomogra-
phy reconstruction of skulls from 5.5 week-old adult Hdac3 CKO
mice showed that the calvarial bones remained extremely thin and
porous through adulthood (Figure 2D and Figure S2). These data
indicated that Hdac3 is necessary for proper intramembranous
bone formation.
Hdac3 Conditional Knockout Mice Have Growth Plate
Defects
The smaller stature of the Hdac3-depleted mice and potential
reduction of Hdac3 levels in cartilage due to osterix expression in
chondrocytes[3,32]prompted theassessment offemoral growth plate
structure. Femur length was decreased 18 to 25% in male Hdac3-
CKO and CKOOsx mice (Figure 3A) and 17% in female mice (data
not shown). The average growth plate depth of male 5.5 week-old
Hdac3-CKOOsx mice was the same size as the average from wildtype
mice and had both proliferating and hypertrophic zones; however,
the hypertrophic zone constituted a larger percentage of the growth
plate in Hdac3- heterozygous and CKO groups than in wildtype mice
(Figure 3B and 3C). Von Kossa staining revealed fewer trabeculi
below the growth plate in 5.5 week-old CKO animals (Figure 3D).
These results suggest that Hdac3 deletion might delay or arrest
terminal chondrocyte differentiation, which could adversely affect
endochondral bone formation; however, the normal femur length of
heterozygous animals despite an extended hypertrophic zone
indicates a severe mineralization defect.
Hdac3 Conditional Knockout Mice Have Low Trabecular
Bone Density
The extent of trabecular bone loss in long bones from Hdac3
CKO mice was measured by microcomputed tomography
(Figure 4). Reconstructions of the trabecular bone in distal femurs
illustrated the striking reduction in bone volume in both CKO and
CKOOsx mice as compared to their wildtype and heterozygous
littermates (Figure 4A). At 5.5 weeks of age, trabecular bone
volume density (BV/TV) in the distal femurs of male CKO mice
was reduced by 75% (Figure 4B). The reductions were due to a
43% decrease in trabecular number (Tb.N) (Figure 4C). Trabec-
ular thickness (Tb.Th) was unchanged (Figure 4D). In accordance
with decreased trabecular number in both groups of Hdac3 CKO
mice, trabecular separation (Tb.Sp) was increased and connectiv-
ity density (ConnD) was decreased in these animals (Figures 4E–F).
Similar differences were also observed in 12 week-old male mice
(Figure S3) and in females (data not shown).
To understand how Hdac3-depletion in osterix-positive cells
affected trabecular bone formation, Goldner’s Trichrome-stained
sections of distal femurs were examined by static histomorphom-
etry (Figure 5). There was no change in the number of osteoblasts
per bone surface (Figure 5A); however, in accordance with the
significant decrease in bone density, there were fewer osteoblasts
per tissue area in the Hdac3 CKO mice as compared to wildtype
and heterozygous littermates (Figure 5B). Osteoclast surface was
slightly elevated in the Hdac3 CKO mice; however the changes did
not reach statistical significance (Figure 5C). These data indicate
that Hdac3 depletion in osterix-expressing cells is detrimental to
bone formation, but that the bony structures present in these
animals remained lined with osteoblasts and osteoclasts.
To determine if osteoblasts in Hdac3 CKOOsx mice produce a
mineralized matrix at the same rate and to the same extent as
wildtype and heterozygous littermates, 5.5 week-old male mice
were injected once with tetracycline and twice with calcein and
newly formed mineralized surfaces were measured (Figure 6A).
The amount of mineralized and double-labeled surface (MS and
dL.S, respectively) per bone surface (BS) were reduced by 38%
and 55%, respectively, in the distal femurs of Hdac3 CKOOsx mice
(Figures 6B and C). Similar to what was observed in the microCT
scans (Figure 4D), trabecular number was decreased in histological
sections (Figure 6D). Trabecular bone formation rates (BFR) per
bone surface and tissue volume were also significantly reduced by
44% and 87%, respectively, in Hdac3 CKOOsx mice (Figures 6E
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as the distance between two labels formed over a defined period of
time, was not altered by Hdac3 deficiency in distal femurs
(Figure 6G). Thus, in the rare places where bone was present
and two labels were detected on a bone surface, the activity of
osteoblasts in the Hdac3 CKOOsx mice was indistinguishable from
that of wildtype mice. Reductions in mineralized surface (30%)
and bone formation rates (50%) were also observed in vertebral
trabeculi (Figures 6H–L). The MAR in vertebrae was reduced by
30% (Figures 6J). Similar results were present in the CKO
(Hdac3
fl/2:Cre
+) mice (data not shown). Together, these data
indicate that there are widespread deficits in trabecular bone
formation in Hdac3 CKO mice.
Hdac3 Conditional Knockout Mice Have Low Cortical
Bone Density
Few naturally occurring fractures were observed in Hdac3 CKO
and CKOOsx mice; however, the long bones broke frequently
along the diaphysis during dissection and processing (Figure 7A),
suggesting cortical bone defects. Fluorochrome-labeling experi-
ments demonstrated dramatic defects in bone formation on the
periosteal and endocortical bone surfaces in both groups of Hdac3
CKO mice (Figure 7B). The bone formation rate, mineral
apposition rate, and mineralized surface percentage were all
significantly decreased in both CKO and CKOOsx mice
(Figure 7C, 7D, and 7E). Meanwhile, mineralization lag time
was increased 5- to 6-fold in the CKO groups (Figure 7F).
Figure 1. Hdac3-deficient mice are smaller and have shorter lifespans. A. PCR amplicons of Hdac3 alleles. B. Western blot analysis of Hdac3
expression in calvaria. C. Representative 5.5 week-old male wildtype (WT) and Hdac3 CKO mice are shown in the left panel. Average weekly weights of
male and female wildtype (closed squares) and Hdac3 CKO (open squares) mice at and after the time of weaning are presented in the graphs. D. Hdac3-
CKOand-CKOOsx micehadshorter lifespansthan wildtypeandheterozygous littermates.Eachsymbol represents amousethat diedfrom naturalcauses.
doi:10.1371/journal.pone.0011492.g001
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Genes Upregulated in Hdac3 CKO Mice Genes Downregulated in Hdac3 CKO Mice
Gene Symbol Fold Change Gene Symbol Fold Change
Cdkn1a 3.4 * S100a8 27.3 *
Ephx1 2.8 * Alas2 22.6 *
Phlda3 2.0 * Ramp1 22.3 *
Plat 2.0 * Rsad2 22.2 *
Tmem178 2.0 * Mepe 22.0 *
AB023957 1.9 * Hdac3 22.0 #
Gstm6 1.9 # Serpina3g 21.9 #
Nrp1 1.8 * Vit 21.9 #
Icam1 1.8 # Hpgd 21.8 #
Tmem43 1.7 # CD59a 21.7 #
Gpnmb 1.7 # Entpd3 21.6 #
LOC10004 1.7 # Sct 21.6 ‘
E430002G 1.7 # Gpihbp1 21.6 #
Slc19a2 1.6 # Hey1 21.6 #
Pax1 1.6 # CD59b 21.6 #
Gas6 1.6 # Icam2 21.6 #
Anxa8 1.6 # Ankrd37 21.5 #
Mmp2 1.6 # Prr15 21.5 ‘
Aaas 1.6 # Cdk5r1 21.5 #
Ahnak2 1.6 # Ndufa1 21.4 ‘
Timp3 1.6 # Rbp7 21.4 ‘
LOC10004 1.6 #
Angptl4 1.6 #
Slc16a9 1.6 #
Slc29a3 1.6 #
Tnfrsf11b/Opg 1.6 ‘
Lgr5 1.6 #
Scd2 1.5 #
Prelp 1.5 #
Bcl11b 1.5 #
Cxcl2 1.5 #
Exoc4 1.5 #
Lgals3bp 1.5 #
Prad1 1.5 ‘
Tpm1 1.5 ‘
Ror2 1.4 ‘
Palld 1.4 #
Sfrp4 1.4 ‘
Col5a1 1.4 ‘
Hmgcs2 1.4 ‘
Polk 1.4 ‘
Axin2 1.4 ‘
Rnf145 1.4 ‘
*3SD;
#.2S D ;
‘ .1S D .
doi:10.1371/journal.pone.0011492.t001
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were reduced more than 60% in the Hdac3 CKOOsx mice
(Figures 7G and 7H). Cortical area and section modulus, which
are estimates of axial strength and bending strength [33], were
reduced 50 and 70%, respectively, in the Hdac3 CKOOsx mice
(Figures 7I and 7J). Together the data presented thus far
demonstrate that Hdac3-deficiency prevents proper calvarial,
trabecular, and cortical bone formation.
Adipogenesis is Increased in Bone Marrow of Hdac3
Conditional Knockout Mice
Bone marrow osteoblasts and adipocytes are derived from
common multipotent mesenchymal progenitor cells and an inverse
correlation between bone and white fat volumes are well
characterized [34]. Goldner’s trichrome-stained sections from
5.5 week-old Hdac3 CKO femurs revealed the presence of a large
number of adipocyte ghosts (Figure 8A). The adipocytes were
present throughout the femur but seemed to be more prevalent
towards the midshaft and along cortical surfaces. Adipocyte
density, perimeter and number were elevated 11- to 25-fold in
both CKO and CKOOsx groups, but not in Het or CHet mice
(Figure 8B–D). Similar increases in adipocyte density were
observed in female animals and in 2 and 4 week-old mice (data
not shown). Adipocytes were not seen in 4 day-old mice (data not
shown), indicating that bone marrow adipogenesis resulting from
Hdac3-deficiency occurred postnatally.
Microarray analysis of Osteoblasts from Hdac3 CKO mice
To understand the molecular changes that result from Hdac3
depletion in osteoblast progenitor cells, the gene expression patterns
in calvarial extracts were determined by microarray analysis and
confirmed by qPCR. Two independent microarray analyses were
Figure 2. Calvarial bone formation is defective in Osx-Cre: Hdac3 CKO mice. A–C. Staining of one day-old wildtype, het (Hdac3
+/2:Osx-Cre
2),
and Hdac3 CKO mice with alizarin red and alcian blue. D. MicroCT reconstructions of skulls from 5.5 week-old wildtype, Het (Hdac3
+/2: Osx-Cre
+), and
Hdac3 CKO mice.
doi:10.1371/journal.pone.0011492.g002
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littermates. In these experiments, 768 and 786 genes were
significantly changed (fold change .1.1, p,0.05 and 95%
confidence) in the Hdac3 CKOOsx mice, but only 176 genes were
present in both data sets (Table S1). Expression changes of 1.4 fold or
greater were verified by qPCRs. With this more stringent cutoff (fold
change .1.4), 64 genes were identified (Table 1). Of these, 43 genes
were upregulated in Hdac3 CKO mice and 21 genes were
downregulated. As expected, Hdac3 was one of these most suppressed
genes. The most upregulated gene in both experiments was cyclin-
dependent kinase inhibitor 1a (Cdkn1a, also known as p21
Cip1), a
known Hdac regulated gene [35,36,37]. In reporter assays we found
that Hdac3 repressed the p21(WAF1/CIP1) promoter in a
concentration dependent manner (Figure S4). Gene ontogeny
analysis of genes differentially regulated more than 1.4-fold identified
11 pathways as being affected by Hdac3 deletion (Figure 9). These
pathways include signal transduction cascades (e.g. Wnt, Akt, G-
proteins), cellcycle and DNA damage pathways, and cytoskeletal/cell
adhesion. Notably, osterix mRNA levels were unchanged (data not
shown). Thus, Hdac3 depletion modulates several pathways that are
crucial for osteoblast development and function.
Discussion
Hdac3 is essential for embryonic development [11,12]. It
associates with numerous transcription factors, co-repressors and
class II Hdacs [18,19,20,21,22]. We previously showed that Hdac3
binds and represses Runx2-dependent activation of osteoblast
genes [24]. In this study, we demonstrate that conditional deletion
of Hdac3 in cells where Cre recombinase is expressed from the
endogenous osterix promoter causes severe deficits in calvarial,
trabecular and cortical bone volume. Some Osx-Cre expressing
mice (Hdac3 wildtype) also had mild skull defects (Figure S5);
however, all Hdac3 CKO mice had severe craniofacial abnormal-
ities. Importantly, none of the most differentially regulated genes
(Table 1) were significantly changed in Osx-Cre mice with wildtype
Hdac3 alleles. Interestingly, incomplete skull bone ossification was
also observed in fetal rats exposed to the Hdac inhibitor vorinostat
in utero [38]. Distal femur trabecular bone volumes were not
affected by the expression of Cre or loss of a single Hdac3 allele
(e.g. CHet mice), but were severely reduced when both copies of
Hdac3 were inactivated. Trabecular and cortical bone formation
rates were markedly depressed in both groups of CKO mice
(Hdac3
fl/fl or fl/2) with concomitant increases in bone marrow fat.
Together these data demonstrate that Hdac3 is essential for proper
osteoblast function and bone formation.
In this study we focused on the postnatal consequences of Hdac3
depletion on bone structural and cellular properties. Because the
Hdac3 CKO mice were smaller than wildtype and heterozyogous
littermates, we also examined growth plates in skeletally immature
mice. The hypertrophic zone was thicker in Hdac3-haploinsuffi-
cient and conditional knockout animals; suggesting that Hdac3
Figure 3. Growth plates are abnormal in Osx-Cre: Hdac3 CKO mice. A. Femurs are shorter in male Hdac3 CKO and CKOOsx mice as compared
to wildtype and heterozygous littermates at 5.5 weeks of age. (n=11 WT, 3 Het, 5 CHet, 7 CKO, and 9 CKOOsx), **p#0.01. B–C. The hypertrophic zone
within growth plates of male mice was measured from Goldner’s trichrome stained sections of the distal femurs. (n=10 WT, 4 Het, 4 CHet, 6 CKO, and
6 CKOOsx), *p,0.05. D Von Kossa staining of representative distal femurs.
doi:10.1371/journal.pone.0011492.g003
Figure 4. Hdac3-depletion in Osx-expressing cells decreases trabecular bone volume in distal femora. A. Representative microCT
reconstructions of trabecular bone in distal femurs. B–F. Structural parameters of distal femurs from microCT reconstructions of 5.5 week-old male
mice. n=5 per group, **p,0.01.
doi:10.1371/journal.pone.0011492.g004
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tion, promote apoptosis, and/or for the onset of ossification.
Interestingly, only animals in the CKO groups (not the Het or
CHet groups) exhibited significant changes in trabecular and
cortical bone structure (Figures 4–7), which likely explains their
smaller stature. Preliminary studies suggest that endochondral
ossification of the bone collar was delayed in neonatal Hdac3 CKO
mice (data not shown). More focused studies are in progress to
determine how Hdac3 participates in the temporal events of
endochondral bone formation.
Two p53 inducible genes, p21
CIP1 and Phlda3 [39,40], were
upregulated in Hdac3 CKO mice. This raises the possibility that
DNA damage might be contributing to defective osteoblast
maturation in the CKO animals (Figure 9B). The cyclin-
dependent kinase inhibitor, p21 (CIP1/WAF1), was the most
upregulated gene in Hdac3 CKO mice and Hdac3 repressed the
basal activity of the p21
Cip1 promoter fragment. We previously
showed that Runx2 represses p21
Cip1 via Hdac-dependent
mechanisms in osteoblasts [25]. p21
Cip1 was one of the first genes
described to be upregulated by Hdac inhibitors [35,36,37] and is
elevated in Hdac1-deficient embryonic stem cells, Hdac2 KO mice
[9,41] and in liver-specific Hdac3 CKO mice [31]. Overexpression
of p21 in osteoblasts blocked proliferation and differentiation [42].
Thus, elevated levels of p21 may interfere with osteoblast
maturation and activity in our Hdac3 CKO mice.
Several other genes and signaling pathways that were affected
by Hdac3 depletion have known roles in osteoblast maturation.
Notably, antagonists of matrix mineralization, matrix gla protein
(Mgp) and ectonucleotide pyrophosphatase (Enpp)1[43,44]were
elevated. We did not observe changes in osteocalcin levels;
however, osteoblast lineage cells are indeed inhibited as a result of
Hdac3 depletion as evidenced by reduced bone formation rates and
the downregulation of genes (e.g. MEPE) expressed by mature
osteoblasts. Inhibitors (Axin2, Ror2, Sfrp4) of the canonical Wnt
signaling pathways were also increased (Figure 9B). Suppression of
Wnt10b signaling may decrease the osteogenic potential and
increase adipogenesis of multipotent mesenchymal cells [45].
Additional experiments beyond the scope of this study are needed
to determine how canonical Wnt signaling is affected by Hdac3-
depletion.
Conditional Hdac3 deletion disrupts metabolic pathways and
activates Ppar nuclear receptors. For example, elimination of
Hdac3 in postnatal liver cells increased the expression of Ppar-
gamma 2 target genes and caused lipid accumulation, hepatocyte
hypertrophy and hepatomegaly [31]. Conditional deletion of
Hdac3 in cardiomyocytes elevated expression of Ppar-alpha target
genes and increased fatty-acid-induced myocardial lipid accumu-
lation and cardiac hypertrophy [12]. Another mouse model, which
globally disrupted the interaction between Hdac3 and Ncor1 (an
activating component of Hdac3 protein complexes), revealed that
this protein pair contributes to circadian and metabolic physiology
[46]. The data reported within show that Hdac3-depletion in
osterix-positive progenitor cells impairs the activities of osteoblasts
derived from these multipotent cells and promotes adipocyte
differentiation. Osterix was previously described as a product of
preosteoblasts and immature chondrocytes [3,32]. Our data
suggest that some of these cells retain the potential to differentiate
into the adipocyte lineage in vivo. The absence of Hdac3 may
promote the activity of Ppar-gamma 2, which is an essential
transcription factor for adipogenesis and binds to Hdac3-
containing co-repressor complexes [47]. Several Ppar-gamma 2-
regulated genes (e,g., Angiopoietin-like 4, Mmp2 [48,49]) were
increased in CKO mice (Table 1). Elevated serum levels of
adiponectin, another Ppar-gamma 2-activated gene, in Hdac3
CKO mice are also consistent with increased Ppar-gamma2
activity (data not shown). Together, the existing mouse models
agree that Hdac3 is a crucial regulator of lipid accumulation in
multiple tissues.
Multiple Hdacs, including Hdac3, regulate osteoblast maturation
in vitro [24,26,27,29,50]. RNAi-mediated Hdac3 suppression in an
immortalized and lineage-committed calvarial cell line, MC3T3-
E1, promoted calcium deposition in the extracellular matrix, and
increasedthe expression ofosteoblastmaturation genes[24].Broad-
acting Hdac inhibitors also promoted osteogenic maturation of
several cell lines, primary calvarial cells and bone marrow-derived
mesenchymal progenitor cells [28,50,51,52,53]. Thus, the results of
this study are inconsistent with several in vitro studies. An
explanation for this discrepancy is that Cre-mediated recombina-
tion of Hdac3 in progenitor cells is a permanent event. By
comparison, small molecule Hdac inhibitors have short half-lives
in serum and might only temporally change chromatin structure
and gene expression in relatively short-term cell culture assays.
Moreover, non-proliferating cells and cells with intact cell cycle
checkpoints are resistant to the toxic effects of Hdac inhibitors
[11,54]. However, this population of cells may still be susceptible to
the sustained effects of Hdac3 deletion in vivo. Thus, the fact that the
decreased osteoblast viability we observed with the in vivo knockout
of Hdac3 was not seen after siRNA suppression of Hdac3 in vitro
may be due to differences in the composition and/or maturity of the
targeted cell populations as well as to the methods used to reduce
Hdac3 expression or function.
In conclusion, Hdac3 is essential for bone formation. Condi-
tional deletion of Hdac3 with osterix-driven Cre recombinase
drastically reduces trabecular and cortical bone formation rates,
bone volume and trabecular number while increasing bone
marrow adipogenesis. Preliminary experiments show that condi-
tional Hdac3 deletion with other osteoblast-specific Cre drivers (i.e.
Col1a1 and osteocalcin) also causes bone loss. These results are
Figure 5. Osteoblast number is decreased in Hdac3-CKO mice. Distal femurs from 5.5 week-old male mice were sectioned and stained with
Goldner’s Trichrome (A and B) or TRAP (C). Osteoblast surface as a proportion of bone surface (Ob.S/BS; A), osteoblast number per tissue area (N.Ob/
T.Ar; B) and osteoclast surface per bone surface (Oc.S/BS; C) were measured with Osteometrics software. n=627, *p,0.05.
doi:10.1371/journal.pone.0011492.g005
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PLoS ONE | www.plosone.org 8 July 2010 | Volume 5 | Issue 7 | e11492Figure 6. Trabecular bone formation rates are lower in Hdac3 CKO mice. A Fluorochrome incorporation in the trabeculi of distal femurs is
decreased in CKO mice. Newly formed trabecular bone in distal femurs (B–G) and vertebrae (H–M) was assessed in 5.5 week old male mice following
two calcein injections using Osteometrics
TM software. (n=5), *p,0.05, **p#0.01.
doi:10.1371/journal.pone.0011492.g006
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inhibitor vorinostat (SAHA) affects skeletal health in a preclinical
cancer model. Although vorinostat inhibited tumor burden in
murine long bones, bone mass of contralateral limbs was
significantly reduced [55]. Vorinostat represses multiple Hdacs
and the data reported here suggest that Hdac3 suppression is
sufficient to decrease bone volume. Our results indicate that
sustained Hdac3 suppression is likely to produce osteopenia and
potentially fractures. Hdac inhibitors are in many clinical cancer
trials and vorinostat is already approved in the United States for
treating cutaneous T cell lymphomas [56]. Hdac inhibitors are
also being considered as possible therapies for several non-
cancerous conditions, including degenerative and inflammatory
disorders [57]. Our data strongly suggest that bone density should
be monitored in any individuals receiving Hdac inhibitors as
therapy. Moreover, future generations of Hdac inhibitors should
be designed to avoid targeting Hdac3 because of multiple organ
(heart, liver and bone) failures in Hdac3-deficient mice [12,31].
Materials and Methods
Mice/Genotyping
Mice were genotyped for Hdac3 alleles as reported [11]. Osx-Cre
transgenic animals were previously described [30]. Animals were
housed in an accredited facility under a 12-hour light/dark cycle
and provided water and food (PicoLabH Rodent Diet 20, LabDiet)
ad libitum. Diets were supplemented three times per week with
Nutri-CalH (Ve ´toquinol Canada Inc, Lavaltrie, QC) and Napa
Nector (SE Lab Group Inc, Napa, CA). For dynamic histomor-
phometry experiments, 5.5 and 12 week-old mice were injected
subcutaneously with tetracycline (25 mg/kg) 7 and 14 days,
respectively, before euthanasia. They were also injected subcuta-
neously twice with calcein (10 mg/kg) at four days and one day
before ending the experiment. All animal research was conducted
according to guidelines provided by the National Institute of Health
and the Institute of Laboratory Animal Resources, National
Research Council. The Mayo Clinic Institutional Animal Care
and Use Committee approved all animal studies.
Whole Mount Embryo Staining
Newborn pups were euthanized and placed in chloroform.
Skeletons were dissected and fixed overnight in ethanol. Cartilage
elements were stained with a 30% Alcian blue dye (dissolved in
80 ml 95% ethanol and 20 ml glacial acetic acid). Skeletons were
washed twice with 95% ethanol and then placed in 2% KOH until
the remaining soft tissues were dissolved. Bones were stained with
75 mg/ml Alizarin red S (Sigma) in 1% KOH overnight and then
Figure 7. Cortical bone is thinner in Hdac3 CKO mice. A. MicroCT reconstructions of tibia and fibulas from WT and Hdac3 CKO mice. Arrows
point to fractures. B–F. Calcein incorporation (B), bone formation rates (C), mineral apposition rates (D), mineralized surfaces (E) were decreased, while
mineralization lag time (F) was increased in Hdac3 CKO mice (n=5 WT and CKOOsx, n=2 CHet, n=3 CKO). G–J. Cortical measurements from microCT
reconstructions demonstrate that periosteal area (Ps.Ar, G), endocortical area (Ec.Ar, H), Cortical area (Ct.Ar), which estimates axial strength (I), and
section (Sec) modulus, an estimate of bending strength (J), were reduced in Hdac3 CKO mice (n=3 per group). *p,0.05, **p,0.01, #p,0.0001.
doi:10.1371/journal.pone.0011492.g007
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solution changes. Skeletons were transferred to a 20% glycerol,
20% ethanol solution overnight and then stored in a 50% glycerol,
50% ethanol solution indefinitely.
Microcomputed Tomography
Bones were dissected from euthanized mice and fixed in 70%
ethanol. Samples were scanned and measured in a Scanco 35
System (Scanco Medical, Switzerland), which was calibrated
monthly with an aluminum rod phantom and weekly with a
hydroxyapatite phantom. Images were reconstructed with cubic
voxels 5.7 mm on a side using a modified Feldkamp cone beam
tomographic reconstruction algorithm. Trabecular bone proper-
ties were calculated with the manufacturer’s software. Cortical
bone geometric properties were measured from femoral mid-shaft
cross-sectional images as previously described [58]. Data from
Hdac3 mutant mice were compared to data from wildtype mice
with student t-tests.
Histomorphometry
After microcomputed tomography scanning, two transverse
sections (,50 microns thick) were cut from the diaphysis of long
Figure 8. Hdac3-depletion in osterix-expressing cells increases adipocyte volume within bone marrow. A. Goldner’s Trichrome stain of
femurs from 5.5 week-old male wildtype and Hdac3-CKO mice. B–D. Adipocyte density (Adipocyte volume/tissue volume (B), perimeter (C), and
number (D) are increased in Hdac3 CKO mice. n=426, *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0011492.g008
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PLoS ONE | www.plosone.org 11 July 2010 | Volume 5 | Issue 7 | e11492Figure 9. Hdac3 depletion alters multiple signaling pathways. A. GeneGo pathway analysis of genes differentially regulated in Hdac3-deficient
calvarial osteoblasts. Data from two independent microarray experiments were analyzed with MetaCore software at a false discovery rate=0.25. B.
Model for defective osteoblast differentiation and increased adipocyte formation in Hdac3-insufficient mice.
doi:10.1371/journal.pone.0011492.g009
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studies. The sections were polished and ground to a thickness of
approximately five microns with a glass plate coated in aluminum
oxide powder, mounted on a microscope slide, and examined with
a fluorescent microscope. For trabecular studies, distal femurs
were dehydrated, embedded in methylmethacrylate and cut
longitudinally into five micron-thick sections. The dynamic
properties of trabecular bone surfaces were assessed on unstained
sections at 200X using the OsteoMetrics
TM system by measuring
the distance between the two calcein labels, while the properties of
the cortical periosteal and endosteal surfaces were determined by
measuring the distance between the tetracycline label and second
calcein label as previously described [59].
For static measures, the distal femurs were embedded in
methylmethacrylate and cut longitudinally into five micron-thick
serial sections. Serial sections were stained with Goldner’s
trichrome or von Kossa to detect mineralized bone, osteoid, cells
and adipocytes; toluidine blue to detect osteoblasts; or TRAP (to
distinguish osteoclasts) for static histomorphometric measures.
Data were collected at 2006 magnification using OsteoMeasure
software. Data from Hdac3 mutant mice were compared to those
from wildtype mice with student t-tests.
Growth Plate Analyses
Femur lengths were measured from the inter-condylar notch to
trochanteric notch using a caliper. The distal femurs of 12-5.5
week-old male mice were embedded in methylmethacrylate and
cut longitudinally into five micron-thick serial sections. Serial
sections were stained with Goldner’s trichrome. A technician blind
to sample identities measured growth plate depth (mm) and
hypertrophic zone depth (mm) with a previously published
technique that was adapted for the KS300 computerized image
analysis system (Carl Zeiss Vision GmbH, Hallbergmoos,
Germany) [60,61]. Briefly, two sections were obtained from each
tissue sample and scanned at the growth plate area using the Zeiss
AuxioCam MRc at the same magnification with the calcification
zone horizontal to the bottom edge of the scan’s frame of
reference. Each growth plate or hypertrophic zone was outlined by
hand. Average thickness was determined by comparing thicknesses
in the outlined area from top to bottom. Values obtained from
sections made from the same tissue sample were then averaged to
give overall mean values for cambium thickness and hypertrophic
zone thickness. Hypertrophic zone thickness was then normalized
to growth plate thickness in order to yield percentage hypertrophic
zone in growth plate. Statistical analysis was done using a student’s
t test and Wilcoxon Rank Sum non-parametric where appropriate.
Statistics are reported with standard deviations.
Calvarial Explants
To enrich for cellular protein and obtain RNA from bone tissue,
calvarial bones from four to five day-old pups were dissected from
soft tissues, rinsed with HBSS, and digested in collagenase
digestion medium [52] on an orbital shaker for 20 minutes at 37
degrees at 125 rpm. Following digestion, explants were washed
once with PBS and snap frozen in liquid nitrogen. The remaining
bone tissues were crushed under liquid nitrogen with a mortar and
pestle and then resuspended in either TRIzol (Invitrogen) for RNA
extraction or modified-RIPA buffer supplemented with protease
inhibitors for protein isolation.
Microarray studies
RNA from calvarial explants was purified using TRIzol
according to the manufacturer’s protocol (Invitrogen) and reverse
transcribed using Qiagen’s Quantitect Reverse Transcription Kit.
Microarray experiments were performed in the Mayo Clinic
Advanced Genomic Technology Center using the Illumina
MouseRef-8 BeadChip array. Two independent experiments were
performed; each experiment used RNA from four wildtype and
four CKO litter-matched mouse calvaria. The raw data from eight
samples in each experiment were pre-processed using Beadstudio
(Illumina Inc, San Diego, CA). Raw data were submitted to the
MIAME-compliant GEO database (Accession number:
GSE21087). Genes that were not expressed in eight calvarial
RNA samples (detection p$0.05) were eliminated from analysis,
leaving 10,500 gene transcripts out of 19,000 for the final analysis.
A paired t-test was used to compare differential gene expression
between the wildtype and CKO groups. Genes with fold changes
greater than 1 standard deviation in both experiments were used
for pathway analysis using MetaCore software (GeneGo Inc, St.
Joseph, MI, USA). Genes that were significantly (1.4 fold, p#0.05)
differentially expressed between the WT and CKO groups were
subjected to reverse transcription (RT) and real-time semi-
quantitative (q) PCR analysis for confirmation.
RT-qPCR
To verify microarray results, calvarial RNA samples from litter-
matched wildtype and CKO mice were reverse-transcribed with
Quantitect Reverse Transcription Kit (Qiagen). Gene specific
primers sequences are available upon request. Real time qPCRs
were performed using 15 ng of cDNA per 10 ml using Bio-Rad iQ
SYBR Green Supermix in the Eppendorf epMotion 5070 and the
Applied Biosystems 7900 HT Fast Real Time PCR System.
Transcript levels were normalized to three housekeeping genes
(YWHAZ, GAPDH, and HRPT1), which were our most stable
osteoblast genes as determined using GeNorm software [62].
Quantification was done using the 2
2DDCt method [63].
Western blotting
Protein extracts from calvarial explants were sonicated and
resolved by SDS-PAGE. Immunoblotting was performed with
antibodies recognizing Hdac3 (1:1000, Abcam, Ab63353).
Luciferase Assays
p21 reporter assays were performed as previously described
[25].
Supporting Information
Figure S1 Photograph of representative 5.5. week-old mice used
in this study. The animals’ weights are listed below the photos.
Found at: doi:10.1371/journal.pone.0011492.s001 (0.57 MB TIF)
Figure S2 MicroCT Reconstructions of skulls from 5.5 week-old
male Hdac3 WT, Het and CKO mice. These are alternative
angles of the microCT reconstructions shown in Figure 1E.
Found at: doi:10.1371/journal.pone.0011492.s002 (0.96 MB TIF)
Figure S3 Hdac3-Depletion in Osx-expressing cells decreases
trabecular bone volume in distal femora. A-E. Structural
parameters of distal femurs from microCT reconstruction of 12
week-old male mice. n=4-5 per group, *p,0.05.
Found at: doi:10.1371/journal.pone.0011492.s003 (0.10 MB TIF)
Figure S4 HDAC3 represses the p21(CIP1) promoter. C2C12
cells were transfected with a p21-luciferase reporter and increasing
concentrations of pCMV-HDAC3. Firefly luciferase activity was
normalized to renilla-luciferase activity to control for transfection
efficiency. Data are shown relative to cells transfected with an
empty CMV vector.
Found at: doi:10.1371/journal.pone.0011492.s004 (0.04 MB TIF)
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mice. Minor craniofacial defects are present in 5.5 week-old Osx-
Cre mice. These mice are wildtype at the Hdac3 loci.
Found at: doi:10.1371/journal.pone.0011492.s005 (0.35 MB TIF)
Table S1 List of the 176 genes common to two independent
microarray experiments.
Found at: doi:10.1371/journal.pone.0011492.s006 (0.14 MB
PDF)
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